The DOI matches its Crossref record; 152 of the 155 references it cites were found in a registry or an index.
Monocyte-Macrophages and T Cells in Atherosclerosis
Open accessAbstract
Atherosclerosis is an arterial disease process characterized by the focal subendothelial accumulation of apolipoprotein-B-containing lipoproteins, immune and vascular wall cells, and extracellular matrix. The lipoproteins acquire features of damage-associated molecular patterns and trigger first an innate immune response, dominated by monocyte-macrophages, and then an adaptive immune response. These inflammatory responses often become chronic and non-resolving and can lead to arterial damage and thrombosis-induced organ infarction. The innate immune response is regulated at various stages, from hematopoiesis to monocyte changes and macrophage activation. The adaptive immune response is regulated primarily by mechanisms that affect the balance between regulatory and effector T cells. Mechanisms related to cellular cholesterol, phenotypic plasticity, metabolism, and aging play key roles in affecting these responses. Herein, we review select topics that shed light on these processes and suggest new treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immunosuppressive drug regimens may have adverse effects on lipid metabolism leading to increases in TC, VLDL, and TGs, and in the size and density of LDL particles.”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [502]
In the citing paper
“These effects vary with different immunosuppressive drugs [497,498,502-506].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [502]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Cytokine-mediated regulation of CXCR4 expression in human neutrophils
Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 4,713
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026 · cited 1×
“Although cholesterol crystals have been implicated in this process (Duewell et al., 2010; Sheedy et al., 2013), other mechanisms are likely to contribute as well (Hoseini et al., 2017).”
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,094
Trained immunity: A program of innate immune memory in health and– disease
Netea, M. G., Joosten, L. A. B., Latz, E., Mills, K. H. G., Natoli, G., Stunnenberg, H. G., O’Neill, L. A. J., & Xavier, R. J. (2016) · Science · doi:10.1126/science.aaf1098 · Cited by 2,768
Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease
Jaiswal, S., Natarajan, P., Silver, A. J., Gibson, C. J., Bick, A. G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701719 · Cited by 2,683
Lakatta, E. G., & Levy, D. (2003) · Circulation · doi:10.1161/01.cir.0000048892.83521.58 · Cited by 2,244
Flagged first, then by citations
3 of the 155 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–650 of 650
Role of Lipoprotein(a) and Blood Cells Ratios in Peripheral Artery Disease
Tyurina, A. V., Afanasieva, O. I., Владиславович, Е. М., Tmoyan, N. A., Балахонова, Т. В., & Pokrovsky, S. N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209918
PCSK9 in critical illness – It’s not all about lipids
Crossley, E., Silversides, J. A., O’Kane, C. M., & Hamilton, P. (2025) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632251395579
Lv, H., Yang, H., Guo, X., Li, J., Xie, Y., Jiang, C., Shi, J., Huang, Q., & Shao, D. (2025) · npj Microgravity · doi:10.1038/s41526-025-00473-0
Verma, S., Kumar, A., Narang, R., Bisoi, A. K., & Mitra, D. K. (2022) · Figshare · doi:10.6084/m9.figshare.19687448
Shen, Y., Xu, L.-R., Tang, X., Lin, C.-P., Yan, D., Xue, S., Qian, R.-Z., & Guo, D.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.14728261
Verma, S., Kumar, A., Narang, R., Bisoi, A. K., & Mitra, D. K. (2022) · Figshare · doi:10.6084/m9.figshare.19687457
Zhang, H., Xia, N., Tang, T., 聂少芳, Zha, L., Zhang, M., Lv, B., Lu, Y., Jiao, J., Li, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26578121
Shen, Y., Xu, L.-R., Tang, X., Lin, C.-P., Yan, D., Xue, S., Qian, R.-Z., & Guo, D.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.14728255
Lawrence, G., Midtervoll, I., Samuelsen, S. O., Kristoffersen, A. K., Enersen, M., & Håheim, L. L. (2022) · Figshare · doi:10.6084/m9.figshare.20410923
Shen, Y., Xu, L.-R., Tang, X., Lin, C.-P., Yan, D., Xue, S., Qian, R.-Z., & Guo, D.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.14728264
Zha, Y., Lu, Y., Zhang, T., Yan, K., Zhuang, W., Liang, J., Cheng, Y., & Wang, Y. (2021) · Figshare · doi:10.6084/m9.figshare.17284100
Shen, Y., Xu, L.-R., Tang, X., Lin, C.-P., Yan, D., Xue, S., Qian, R.-Z., & Guo, D.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.14728258
Zhang, H., Xia, N., Tang, T., 聂少芳, Zha, L., Zhang, M., Lv, B., Lu, Y., Jiao, J., Li, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26578100
Lawrence, G., Midtervoll, I., Samuelsen, S. O., Kristoffersen, A. K., Enersen, M., & Håheim, L. L. (2022) · Figshare · doi:10.6084/m9.figshare.20410926
Shen, Y., Xu, L.-R., Tang, X., Lin, C.-P., Yan, D., Xue, S., Qian, R.-Z., & Guo, D.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.14728270
Shen, Y., Xu, L.-R., Tang, X., Lin, C.-P., Yan, D., Xue, S., Qian, R.-Z., & Guo, D.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.14728267
Liu, Q., Wu, X., & Shi, J. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1613138
Protective Effects of Lingonberry Against Cardiovascular Disease and Its Associated Risk Factors
Hewage, S. M., Prashar, S., Karmin, O., & Siow, Y. L. (2026) · Advances in biochemistry in health and disease · doi:10.1007/978-3-032-14441-6_20
Ferroptosis in Spine-Related Diseases: Mechanistic Insights and Potential Therapeutic Targets
Weng, Z., Zheng, H., Dong, H., Zhu, L., Liao, W., Xia, J., Yi, J., Feng, S., Jiang, H., & Xin, Z. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01668-z
Yao, D., Meng, P., Huang, B., Wu, R., Lin, Z., Li, K., Wu, L., Xia, P., Liu, Q., Wu, W., et al. (2026) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-025-10723-x
Aghjehroud, H. N., alizadeh, R., Faraj, A. M., Aghazadeh, H., Aboulhassanzadeh, S., & Aboulhassanzadeh, S. (2026) · Research Square · doi:10.21203/rs.3.rs-7393034/v1
Liu, L., Zhao, G., Gao, Q., Zhao, Y., Ma, J., Zhao, K., Wu, Q., & Xu, G. (2026) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2026.03.011
Role of Ro60/RNYs complex in lipid-laden macrophages
Fazio, S. (2020) · theses.fr (ABES) · doi:10.70675/cbb164cfz48acz4848zbf5bzed9d16dc6f7a
Hardy, L. M. (2019) · theses.fr (ABES) · doi:10.70675/2f5f4b0dzc92fz4cb4z9c5bzeb6d3fd3e791
Mathematical modeling of atherosclerosis
Younes, G. A. (2022) · doi:10.70675/aa27edf7z3297z49a6zbeb1z1520950bd883
Tussilagone mitigates sepsis-induced acute lung injury in mice by suppressing RIPK1 expression
Gu, J., Cai, Y., Yin, J., Zhang, M., Chen, J., & Miao, H. (2026) · Hereditas · doi:10.1186/s41065-026-00678-7
CD8+ T cells in atherosclerosis and coronary artery disease
Tandon, I., yosri, M., Soliman, H., Khalifa, A. M., Ley, K. F., & Abdelsamed, H. A. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01295-7 · Cited by 1
de Oca, S. V. M., Acedo-Terrades, A., Martinez, J. F. C., Kirchner, P., Örd, T., Kaikkonen, M. U., Wei, S., Freigang, S., Zlobec, I., & Martínez, M. R. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.15.725379
Meng, X., & Wang, C. (2026) · Immunological Investigations · doi:10.1080/08820139.2026.2680482
Fisetin-mediated MYC restoration improves age-associated decline in macrophage functionPreprint
Kimble, J. V., Moss, C. E., Hodge, L. S., Clements, M., Rayson, A., Roberts, K. S., West, R. J. H., Evans, I. R., Francis, S., Bellantuono, I., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.10.731325
Esina, E. Y., Михайлович, С. А., & Litavrina, V. G. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2026-6605
Jin, Y. H., Xu, L., Xiong, Y., Sun, D., Liu, L., Lu, X., Yuan, Y., Yang, N., Ren, Z., Lu, D., et al. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.323765
Lv, N., Tang, Y., Zhang, W. K., Zhang, Q., Zhang, H., Gao, H., Cui, S., Krasny, S., & Shi, L. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01823-5
Chu, J., Zhuang, J., Han, S., Liang, Y., Mao, J., Zian, Z., Chu, C., & Yang, X. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00090.2026
A DLL1-culture system to propagate murine patrolling monocytes from bone marrow progenitors
Silva, J. A. F. D., Nagra, A., Wadhwa, A., Mar, S., Tjoa, A., Flibotte, S., Barvalia, M., Matos, I., Priatel, J. J., Krebs, D. L., et al. (2026) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiag103
Nihira, K., Yanagihara, Y., Nakamura, Y., Chelvanambi, S., Halu, A., Lee, L. H., Mojcher, A., Higashi, H., Yamada, I., Qiao, J., et al. (2026) · Science Advances · doi:10.1126/sciadv.ady4193
Yodsanit, N., Lapmanee, S., Bunwatcharaphansakun, P., Hooncharoen, K., Asawapirom, U., Leamkom, N., Pattawanwiwek, K., Khongkow, M., & Namdee, K. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108823
Prodrug Strategies in Atherosclerosis: Targeted Delivery and Therapeutic Advances
Mirhadi, E., Almahmeed, W. A., Kesharwani, P., & Sahebkar, A. (2026) · Cardiovascular Therapeutics · doi:10.1155/cdr/5159097
Natural killer cells in preeclampsia: an overview of current research
Zhang, Y., Su, H., Zhang, Y., Chen, Q., Meng, Y., Zhang, C., Bi, X., Li, Q., & Yang, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1734660
Ke, X., Li, L., Luo, X., 邓晨, Liu, Y., Chen, J., Ruan, H., Duan, W., Zhao, J., Zhai, Y., et al. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103608
RetractedZeng, X., Nie, Y., Zhang, Z., Quan, Y., Ye, G., Deng, P., & Leng, Y. (2026) · International Journal of Cardiology · doi:10.1016/j.ijcard.2026.134762
Jiang, C., Ma, Y., Deng, S., Wan, D., & Zhou, P. (2026) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-026-07955-7
Red blood cell aggregation and atherosclerosis: Curvilinear clinical implications
Wang, Y., Chen, Y., & Yan, C. (2026) · Clinical Hemorheology and Microcirculation · doi:10.1177/13860291261470519
Immune Dysregulation as a Driver of Coronary Heart Disease
Chu, S., Zhou, H., & Wan, H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209149
Zhang, J., Zhao, Q., Wu, Y., Shu, K., Chen, J., Li, K., Feng, Y., Xu, Z., Liu, W., Lai, Z., et al. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70856
Shao, W., Zhang, Y., Luo, H., & Huang, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1968525
Muhammad, W., Savova, G., Tacheva, B., Zheng, W., Paarvanova, B., & Gao, C. (2026) · Materials Today Advances · doi:10.1016/j.mtadv.2026.101047
Metadata
- Authors
- Tabas, I., & Lichtman, A. H.
- Affiliations
- Columbia University Irving Medical Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Tabas, Ira
- Lichtman, Andrew H.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 47
- Issue
- 4
- Pages
- 621-634
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC5747297
- OpenAlex
- W2766451938
- Cited by
- 646
- References
- 155
- Citations by year
- 2026: 53 · 2025: 57 · 2024: 72 · 2023: 65 · 2022: 86 · 2021: 102 · 2020: 80 · 2019: 78 · 2018: 49 · 2017: 4
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (R01 HL132412, HL127464, HL075662, P01 HL087123, R01 HL087282, HL131862)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- atherosclerosis, monocytes/macrophages, T cells, innate immune response, adaptive immune response, damage-associated molecular patterns, apolipoprotein B-containing lipoproteins, macrophage activation, regulatory T cells, effector T cells, chronic inflammation, thrombosis, hematopoiesis, cholesterol, phenotypic plasticity, aging, atherosclerosis treatment
- MeSH terms
- Animals, Humans, Immunity, Innate, Lipoproteins, Macrophages, Monocytes, T-Lymphocytes, Models, Immunological, Atherosclerosis, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review